These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8518505)

  • 1. Complement activation and sensitizing antibodies in Lyme borreliosis. A microbial adherence immobilization assay for Borrelia burgdorferi (MAIA-BB).
    Cacciapuoti B; Ciceroni L; Fontana L; Perricone R
    Zentralbl Bakteriol; 1993 Feb; 278(1):102-11. PubMed ID: 8518505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complement-killing of Borrelia burgdorferi. Target antigens and sensitizing antibodies.
    Cacciapuoti B; Ciarrocchi S; Ciceroni L
    Zentralbl Bakteriol; 1998 Jul; 288(1):121-9. PubMed ID: 9728412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to Borrelia burgdorferi in sheep and goats. Alto Adige-South Tyrol, Italy.
    Ciceroni L; Simeoni J; Pacetti AI; Ciarrocchi S; Cacciapuoti B
    New Microbiol; 1996 Apr; 19(2):171-4. PubMed ID: 8722314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis.
    Dressler F; Ackermann R; Steere AC
    J Infect Dis; 1994 Feb; 169(2):313-8. PubMed ID: 8106763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth inhibition of Borrelia burgdorferi sensu lato by antibodies. A contribution to understanding the pathogenesis and improving diagnosis of Lyme borreliosis].
    Sadziene A; Barbour AG
    Wien Med Wochenschr; 1995; 145(7-8):162-5. PubMed ID: 7610664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement.
    Bockenstedt LK; Barthold S; Deponte K; Marcantonio N; Kantor FS
    Infect Immun; 1993 May; 61(5):2104-7. PubMed ID: 8478100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation.
    Krause A; Brade V; Schoerner C; Solbach W; Kalden JR; Burmester GR
    Arthritis Rheum; 1991 Apr; 34(4):393-402. PubMed ID: 2012626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete.
    Lovrich SD; Callister SM; Schmitz JL; Alder JD; Schell RF
    Infect Immun; 1991 Aug; 59(8):2522-8. PubMed ID: 1855973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of antibodies to Borrelia burgdorferi in sarcoidosis.
    Arcangeli G; Calabro S; Cisno F; Zambotto FM; Drigo R; Ferraresso A
    Sarcoidosis; 1994 Mar; 11(1):32-3. PubMed ID: 8036340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Borrelia burgdorferi from a Lyme seronegative patient in northern Italy: expression of OspB immunodominant proteins on the isolated strain.
    Cinco M; Trevisan G; Agolzer A
    Microbiologica; 1992 Apr; 15(2):95-8. PubMed ID: 1602993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
    Rousselle JC; Callister SM; Schell RF; Lovrich SD; Jobe DA; Marks JA; Wieneke CA
    J Infect Dis; 1998 Sep; 178(3):733-41. PubMed ID: 9728542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
    Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
    Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to Borrelia burgdorferi in European bison (bison bonasus) from Białowieza Primeval Forest.
    Siński E; Gill J; Rijpkema S
    Rocz Akad Med Bialymst; 1996; 41(1):111-6. PubMed ID: 8673795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodiagnosis of Lyme borreliosis.
    Dattwyler RJ; Luft BJ
    Rheum Dis Clin North Am; 1989 Nov; 15(4):727-34. PubMed ID: 2685927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.
    Preac Mursic V; Marget W; Busch U; Pleterski Rigler D; Hagl S
    Infection; 1996; 24(1):9-16. PubMed ID: 8852456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Lyme borreliosis by an enzyme immunoassay detecting immunoglobulin G reactive to purified Borrelia burgdorferi cell components.
    Bergström S; Sjöstedt A; Dotevall L; Kaijser B; Ekstrand-Hammarström B; Wallberg C; Skogman G; Barbour AG
    Eur J Clin Microbiol Infect Dis; 1991 May; 10(5):422-7. PubMed ID: 1874248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mimicry and Lyme borreliosis.
    Sigal LH
    Ann Neurol; 1990 Aug; 28(2):195-6. PubMed ID: 1699473
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
    Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
    J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.